Literature DB >> 12359141

Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.

Wendy J Introne1, Chanika Phornphutkul, Isa Bernardini, Kevin McLaughlin, Diana Fitzpatrick, William A Gahl.   

Abstract

In alkaptonuria, homogentisate 1,2-dioxygenase deficiency causes tissue accumulation of homogentisic acid (HGA), followed by signs and symptoms of ochronosis. These include massive urinary excretion of HGA, arthritis and joint destruction, pigmentation of cartilage and connective tissue, and cardiac valve deterioration. We describe a 46-year-old man with alkaptonuria and diabetic renal failure whose plasma HGA concentration was twice that of any other alkaptonuria patient, and whose ochronosis progressed much more rapidly than that of his two alkaptonuric siblings. After renal transplantation, the plasma HGA normalized, and the daily urinary excretion of HGA decreased by 2-3g. This case illustrates the critical role of renal tubular secretion in eliminating HGA from the body, and suggests that renal transplantation in a uremic patient not only restores HGA excretion, but may also provide homogentisate 1,2-dioxygenase activity for the metabolism of HGA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359141     DOI: 10.1016/s1096-7192(02)00121-x

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  18 in total

1.  A 3-year randomized therapeutic trial of nitisinone in alkaptonuria.

Authors:  Wendy J Introne; Monique B Perry; James Troendle; Ekaterini Tsilou; Michael A Kayser; Pim Suwannarat; Kevin E O'Brien; Joy Bryant; Vandana Sachdev; James C Reynolds; Elizabeth Moylan; Isa Bernardini; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-05-06       Impact factor: 4.797

Review 2.  The role of nitisinone in tyrosine pathway disorders.

Authors:  Edward Lock; Lakshminarayan R Ranganath; Oliver Timmis
Journal:  Curr Rheumatol Rep       Date:  2014-11       Impact factor: 4.592

Review 3.  Alkaptonuria in France: past experience and lessons for the future.

Authors:  Robert Raphael Aquaron
Journal:  J Inherit Metab Dis       Date:  2011-09-17       Impact factor: 4.982

Review 4.  Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review.

Authors:  Alexander A Fisher; Michael W Davis
Journal:  Clin Med Res       Date:  2004-11

Review 5.  Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.

Authors:  Jean-Baptiste Arnoux; Kim-Hanh Le Quan Sang; Anais Brassier; Coraline Grisel; Aude Servais; Julien Wippf; Sandrine Dubois; Nicolas Sireau; Chantal Job-Deslandre; Lakshminarayan Ranganath; Pascale de Lonlay
Journal:  J Inherit Metab Dis       Date:  2015-04-10       Impact factor: 4.982

6.  Relationship Between Serum Concentrations of Nitisinone and Its Effect on Homogentisic Acid and Tyrosine in Patients with Alkaptonuria.

Authors:  Birgitta Olsson; Trevor F Cox; Eftychia E Psarelli; Johan Szamosi; Andrew T Hughes; Anna M Milan; Anthony K Hall; Jozef Rovensky; Lakshminarayan R Ranganath
Journal:  JIMD Rep       Date:  2015-03-13

Review 7.  Acute fatal metabolic complications in alkaptonuria.

Authors:  A S Davison; A M Milan; J A Gallagher; L R Ranganath
Journal:  J Inherit Metab Dis       Date:  2015-11-23       Impact factor: 4.982

8.  Cerebro-spinal and renal ochronosis: A rare case report.

Authors:  Sunil Kumar Nanda; D R Suresh; A Vamseedhar; K Pratibha; B Arjun
Journal:  Indian J Clin Biochem       Date:  2010-05-27

Review 9.  Alkaptonuria.

Authors:  Jemma B Mistry; Marwan Bukhari; Adam M Taylor
Journal:  Rare Dis       Date:  2013-12-18

Review 10.  Chemical individuality: concept and outlook.

Authors:  W A Gahl
Journal:  J Inherit Metab Dis       Date:  2008-10-07       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.